title: Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism. The Research Unit of the Royal College of Physicians of London, the Endocrinology and Diabetes Committee of the Royal College of Physicians of London, and the Society for Endocrinology.
authors.affiliation: Department of Diabetes and Endocrinology, City General Hospital, Stoke on Trent.
authors.forename: M P
authors.initials: MP
authors.lastname: Vanderpump
authors.forename: J A
authors.initials: JA
authors.lastname: Ahlquist
authors.forename: J A
authors.initials: JA
authors.lastname: Franklyn
authors.forename: R N
authors.initials: RN
authors.lastname: Clayton
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D002231:Carbimazole / Q000627:therapeutic use; D005260:Female; D005315:Fetal Diseases / Q000628:therapy; D006801:Humans; D006980:Hyperthyroidism / Q000175:diagnosis / Q000628:therapy*; D007037:Hypothyroidism / Q000175:diagnosis / Q000628:therapy*; D007457:Iodine Radioisotopes / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000628:therapy; D011441:Propylthiouracil / Q000627:therapeutic use; D012017:Referral and Consultation; D013960:Thyroid Function Tests; D013965:Thyroidectomy; D013974:Thyroxine / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000319:Adrenergic beta-Antagonists; D007457:Iodine Radioisotopes; D011441:Propylthiouracil; D002231:Carbimazole; D013974:Thyroxine